Cardiac Blood Tests: Troponin, BNP & Cardiac Enzymes
Cardiac blood tests explained: what troponin, BNP/NT-proBNP and cardiac enzymes measure, when they're ordered, normal ranges in US units, and how to read them.
Cardiac blood tests are the group of blood tests that look at the health of your heart — the cardiac markers. Two do most of the heavy lifting: troponin, which signals injury to the heart muscle (above all a heart attack), and BNP / NT-proBNP, which points toward heart failure. Older cardiac enzymes such as CK, CK-MB, LDH and AST once filled this role but have largely been replaced. The key thing to understand up front is that these results are never read alone: a cardiac blood test completes the physical exam, the electrocardiogram (ECG) and imaging (an echocardiogram) — it does not replace them. This hub explains what cardiac blood tests are, when they are ordered, the main cardiac markers (with a link to each dedicated guide), their normal ranges in US units, and how they are interpreted. The reading always belongs to your clinician, and values vary from lab to lab.
Emergency first. If you have chest pain — pressure, tightness, or squeezing, especially if it spreads to the arm, jaw, or back, with shortness of breath, sweating, or nausea — call 911 now. Do not try to check your own cardiac markers, and do not wait. This guide is informational and does not replace emergency care or your physician.
Key takeaways
- Cardiac blood tests (the cardiac markers) measure heart-related proteins and hormones; they complete the physical exam, the ECG, and imaging — they never replace them.12
- Troponin is the reference marker for heart-muscle injury (a heart attack). It is an emergency test, read on its rise and fall over 1–3 hours, never on a single number.34
- BNP / NT-proBNP points toward heart failure and is prized for ruling it out: a low value makes heart failure unlikely.56
- Indicative US reference points: hs-cTnT below ~14 ng/L; NT-proBNP below 125 pg/mL (outpatient); CK roughly 40–200 U/L (men) / 30–150 U/L (women) — always confirm against your report, since values change with the assay and lab.371
- The classic cardiac enzymes — CK / CK-MB, LDH, AST, myoglobin — have been replaced by troponin for diagnosing a heart attack; CK today is mainly a muscle test.18
- A cardiac work-up often travels with a cardiovascular-risk panel — a lipid panel, blood sugar / A1c, and sometimes hs-CRP — because prevention rests on your overall risk, not on any one marker.92
What are cardiac blood tests?
The heart is a muscle (the myocardium) that pumps blood without pause. When it is under strain — from lack of oxygen, an excess workload, inflammation, or a rhythm problem — certain proteins and hormones spill into the blood. A cardiac blood test measures these cardiac markers to detect and characterize a heart problem.
It helps to separate two different questions, answered by two families of markers:
- "Is the heart muscle being injured?" → troponin (and, historically, enzymes such as CK-MB). Damage to heart-muscle cells releases troponin: the signal of a heart attack and, more broadly, of any myocardial injury.3
- "Is the heart overwhelmed by an overload?" → BNP / NT-proBNP, hormones that rise when the heart's walls are stretched by pressure or volume overload: the markers of heart failure.6
One point is essential: a blood test gives only part of the picture. The heart is also — and mainly — evaluated with the ECG, the echocardiogram (a heart ultrasound), and sometimes a stress test, a Holter monitor, or a coronary angiogram. Markers point; imaging and the ECG confirm. It is the way they are cross-referenced that makes a diagnosis — which is why you should never read a heart blood test on your own.106
Why they're measured
A cardiac blood test answers a specific clinical question, not a routine screen:
- Chest pain or a suspected heart attack — the emergency situation, above all others. In the ER, troponin is measured and then repeated at 1 or 3 hours to rule out or confirm an acute coronary syndrome.104 When you have chest pain, you do not wait for a blood test — you call 911.2
- Shortness of breath or signs of heart failure — leg swelling, rapid weight gain, breathlessness on exertion and then at rest. BNP / NT-proBNP helps separate a cardiac cause from a lung cause, and is measured repeatedly to follow known heart failure alongside the echocardiogram.56
- Cardiovascular-risk assessment — in a person at risk (high blood pressure, diabetes, smoking, high cholesterol, family history), the clinician mainly estimates risk with a lipid panel, blood sugar / A1c, and the exam. Injury markers such as troponin and BNP are not part of routine prevention.9
On "how often" or "at what age," there is no universal schedule: the frequency depends on your risk and your symptoms, and your clinician sets it.
Troponin: the heart-attack test
Troponin (troponin T or troponin I, now measured with high-sensitivity assays, hs-cTn) is a protein of the heart muscle that leaks into the blood when heart cells are injured. It is the reference marker for a heart attack (myocardial infarction) and, more broadly, any myocardial injury.3 Three points matter most:
- It is an emergency test. With chest pain, you call 911 — you do not "get a troponin" at home.2
- A high troponin is not always a heart attack. Myocarditis, pulmonary embolism, kidney disease, sepsis, atrial fibrillation, or intense exercise can all raise it.3
- What counts is the kinetics — the change between two draws 1–3 hours apart — and the context, not an isolated number.4
Because high-sensitivity assays detect tiny amounts of troponin, hospitals now use accelerated protocols: the 0/1-hour and 0/3-hour algorithms pair a first draw with a second one a short time later, comparing the delta.11 A sharp, rising elevation points toward an acute event; a mildly elevated but stable value (common with chronic kidney disease) more often reflects chronic injury without a coronary emergency.43 A normal ECG does not rule out a heart attack — so if the ER draws your blood twice, that is normal and reassuring: it is how the diagnosis is made properly.
BNP / NT-proBNP: heart failure
BNP and NT-proBNP are hormones (natriuretic peptides) the heart releases when its walls are overstretched by a pressure or volume overload. Their level rises above all in heart failure.6 Their great strength is their exclusion value: a low result makes heart failure unlikely and often spares patients unnecessary imaging. In the landmark PRIDE study of emergency-department patients with sudden breathlessness, an NT-proBNP below 300 pg/mL ruled out acute heart failure with a 99% negative predictive value.5
A high value, on the other hand, points without proving: it must be confirmed by an echocardiogram and the clinical picture.6 Several factors move the number independently of heart failure — age and kidney disease push it up, while obesity pushes it down, so a "normal" result can be falsely reassuring in someone with excess weight. BNP and NT-proBNP are also two different tests in pg/mL with their own cutoffs: never compare a BNP number to an NT-proBNP threshold. On the heart-failure drug sacubitril/valsartan (Entresto), BNP rises artificially while NT-proBNP stays reliable, which is why NT-proBNP is preferred for monitoring.6
CK, CK-MB and older cardiac enzymes
Before troponin, doctors leaned on a set of cardiac enzymes to detect a heart attack: CK (creatine kinase), a muscle enzyme, and especially its heart fraction CK-MB, along with LDH (lactate dehydrogenase), AST (aspartate aminotransferase), and myoglobin. All have been replaced by troponin, which is far more sensitive and specific to the heart.18
Today, a total CK measured on its own mostly reflects your muscles — hard exercise, statin-related muscle effects, hypothyroidism, or, at very high levels, rhabdomyolysis (massive muscle breakdown, a medical emergency).1 Do not confuse it with creatinine, which is about the kidneys. CK-MB, LDH, AST and myoglobin may still appear on some panels, but only as historical cardiac markers — the heart-attack question is now answered by troponin.
Normal ranges
Here are indicative US adult reference points, in the units printed on US lab reports. Read every number against the interval on your own report.
| Marker | What it reflects | Indicative adult reference |
|---|---|---|
| Troponin (hs-cTnT) | Heart-muscle injury (heart attack) — emergency | below ~14 ng/L (99th percentile) |
| hs-cTnI (troponin I) | Same, different assay — sex-specific cutoffs | ~ below 34 (men) · below 16 (women) ng/L |
| NT-proBNP — outpatient | Heart strain / heart failure | below 125 pg/mL |
| BNP — outpatient | Same (a different molecule) | below ~35 pg/mL |
| CK / total creatine kinase | Muscle enzyme (heart only via CK-MB, now dated) | men ~40–200 · women ~30–150 U/L |
Read the units and the assay. These cutoffs are orders of magnitude that vary with the lab and the assay — in particular troponin T versus I, whose thresholds are not comparable, with sex-specific cutoffs for troponin I. In the acute setting (the ER), NT-proBNP uses no single cutoff but thresholds that rise with age (roughly 450 pg/mL under 50, 900 for 50–75, 1800 over 75). The number that counts is on your report.37
What high results mean
Three principles guide how a cardiac blood test is read — and explain why you should never self-interpret a number.
1. Troponin is read on its trend, not in isolation. A single value rarely settles anything. US and European practice rely on serial high-sensitivity draws (the 0/1-hour or 0/3-hour algorithms), comparing the change.4 Guidelines deliberately separate a myocardial infarction (injury from a blocked coronary artery with signs of ischemia) from simple myocardial injury of any other cause.3
2. BNP / NT-proBNP is valued mostly for exclusion. Below the cutoff (NT-proBNP under 125 pg/mL outpatient, under 300 pg/mL in the ER), heart failure is unlikely.5 Above it, the result does not confirm the diagnosis: an echocardiogram and the clinical picture do.6 Remember that age and kidney disease raise the number while obesity lowers it.
3. Never a lone value, never without context. Troponin and BNP/NT-proBNP can be high together (severe heart failure, a large pulmonary embolism), but they do not measure the same thing: one an injury, the other an overload. It is their cross-referencing — with the ECG, imaging, your symptoms, and your history — that gives the work-up meaning, and that belongs to the clinician.106
One reassurance: a raised cardiac marker is not a cancer marker. Troponin and BNP reflect the heart, CK the muscles — none points to a tumor.
When to worry / seek emergency care
The most important message of this hub has nothing to do with a number on a report: chest pain is an emergency. If you feel pressure, tightness, squeezing, or pain in the chest — especially spreading to the arm, jaw, neck, or back, with shortness of breath, sweating, nausea, or lightheadedness — call 911 immediately.29 Do not drive yourself, do not "wait to see if it passes," and do not try to check your own cardiac markers. Women, older adults, and people with diabetes may have atypical symptoms — unusual fatigue, breathlessness, or upper-abdominal discomfort rather than crushing chest pain — so when in doubt, treat it as an emergency.9
Between emergencies, some signs deserve a prompt (non-emergency) call to your clinician: new or worsening breathlessness on exertion, swelling of the ankles or legs, rapid weight gain, or waking at night short of breath can all signal heart failure worth evaluating with a BNP/NT-proBNP and an echocardiogram.6 But those are appointments — not a substitute for calling 911 the moment chest pain suggests a heart attack.
Recent research
According to recent publications indexed on PubMed and current US/European guidelines:
- Fast, safe rule-out for chest pain. The 2023 ESC guidelines for acute coronary syndromes confirm high-sensitivity troponin and the 0/1-hour algorithm: two draws an hour apart safely rule out or rule in a heart attack with very few missed events and a shorter ER stay.104
- A definition that broadened the reading. The Fourth Universal Definition of Myocardial Infarction (2018) separates a heart attack from simple myocardial injury and puts high-sensitivity troponin at the center of diagnosis — reinforcing that a high troponin does not equal a heart attack without a rise/fall pattern plus signs of ischemia.3
- Natriuretic peptides anchor the heart-failure work-up. The 2022 AHA/ACC/HFSA heart-failure guideline recommends BNP/NT-proBNP for diagnosis, staging, and prognosis, building on the PRIDE study, in which an NT-proBNP below 300 pg/mL excluded acute heart failure with a 99% negative predictive value.65
- Weighing the result in context. A 2024 review confirms the strong exclusion value of natriuretic peptides and reminds clinicians to adjust for age, kidney function, and obesity.12
These findings concern diagnosis and management in a medical setting; they do not authorize any self-treatment and do not replace your physician's advice — nor a 911 call for chest pain.
Get your cardiac blood tests interpreted by AI DiagMe
Cardiac blood tests are never read marker by marker: the meaning of a troponin depends on its trend, the ECG, and your symptoms; a BNP / NT-proBNP depends on your age, your kidneys, your body weight, and the echocardiogram. It is that cross-referencing that matters.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole context into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician — and never replaces emergency care for chest pain.
Frequently asked questions
What are cardiac blood tests?
What are cardiac enzymes?
What are the cardiac markers in a blood test?
What are normal cardiac marker levels?
What does a high cardiac marker mean?
Does a high cardiac marker mean a heart attack?
Do I need to fast for cardiac blood tests?
How often should I get cardiac blood tests?
Bottom line
Cardiac blood tests bring together the cardiac markers of the heart: above all troponin (heart-muscle injury, an emergency test) and BNP / NT-proBNP (heart failure, with strong exclusion value), while the older cardiac enzymes — CK / CK-MB, LDH, AST, myoglobin — have been replaced by troponin, leaving CK as mostly a muscle test. Keep the landmarks in mind (hs-cTnT below ~14 ng/L, NT-proBNP below 125 pg/mL outpatient, CK ~40–200 / 30–150 U/L), remember they vary by lab, and that these tests complete the exam, the ECG, and imaging without replacing them. Troponin is read on its trend, BNP on its power to exclude, and never as a lone value. Most important of all: with chest pain, call 911. It is your whole picture your clinician reads, and that AI DiagMe can help clarify, alongside (never instead of) medical care.
Sources
Official US sources and peer-reviewed publications (PubMed) used for this guide:
Footnotes
-
Testing.com — Cardiac Biomarkers. testing.com ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
American Heart Association — Troponin and Heart Disease Tests. heart.org ↩ ↩2 ↩3 ↩4 ↩5
-
Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol, 2018. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12
-
Twerenbold R, et al. Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol, 2019. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Januzzi JL, et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol, 2005. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5
-
Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol, 2022. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Natriuretic Peptide Tests (BNP, NT-proBNP). medlineplus.gov ↩ ↩2 ↩3
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Troponin Test. medlineplus.gov ↩ ↩2 ↩3
-
National Heart, Lung, and Blood Institute (NHLBI, NIH) — Heart Attack. nhlbi.nih.gov ↩ ↩2 ↩3 ↩4
-
Byrne RA, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4
-
Cleveland Clinic — Troponin Test. my.clevelandclinic.org ↩
-
Vergani M, et al. The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes. J Clin Med, 2024. PubMed · DOI ↩